| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |